Skip to main content
SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Approved in-office lab list

Date: July 20, 2022 

Attention: All ProvidersEffective date for procedure code 83655, lead screening: June 22, 2021Call to action: This alert is to serve as a reminder of the specific labs on our pre-approved list that may be run in a network provider’s office. 

How this impacts providers: Providers may perform specific point of care lab tests in their office and receive reimbursement from TCHP. All other lab tests should be referred to TCHP in network labs or State of Texas Laboratories. Per state regulations, laboratory specimens that are required to be sent to state laboratories for processing will continue to follow guidelines available here: https://www.dshs.texas.gov/lab/remotedata.shtm

As a reminder, all genetic testing requires a prior authorization, with the exception of Cystic Fibrosis and Spinal Muscular Atrophy Screening effective June 1, 2021, even when processed by an in network lab. The prior authorization form is available here

Lead  Screening

 Initial blood lead testing using point-of-care testing, procedure code 83655. This code can only be billed by a physician in an office setting (POS 11) when it is billed with modifier QW to a THSteps visit per guidance from TMPPM, Children Services Handbook, section 5.3.11.6.6. Providers must have a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver. 

Blood lead testing is part of the encounter rates for FQHCs and RHCs and is not reimbursed separately. 

Reporting all blood lead levels is a law in Texas. For more information, https://www.dshs.texas.gov/lead/Reporting-Laws-Administrative-Code.aspx 

Next steps for providers: Providers may only perform the following pre-approved labs in their office and bill with the correct CPT code:

CPTTest Description
83655Lead screening
80061Lipid Panel
81000Urinls Dip Stick/Tablet Reagnt Non-Auto Micrscpy
81001Urinalysis with Microscopy, Automated
81002Urnls Dip Stick/Tablet Rgnt Non-Auto w/o Micrscp
81003Urinalysis w/o Microscopy, Automated.
81005Urinalysis, Qualitative
81007Urine Screen for Bacteria
81025Urine Pregnancy Test Visual Color Cmprsn Meths
82009Acetone or Other Ketone Bodies
82044Urine Dipstick for Micro-Albumin
82120Amines Vaginal Fluid Qualitative
82247Bilirubin Total
82270Blood Occult Peroxidase Actv Qual Feces 1 Deter
82465Cholesterol Serum/Whole Blood Total
82731Ftl Fibronectin Cervicovag Secretions Semi-Quan
82947Glucose Quantitative Blood Xcpt Reagent Strip
82948Glucose, Blood Reagent Strip
82950Glucose Post Glucose Dose
82948Glucose Blood Test
83036Hemoglobin A1C
83037Hemoglobin A1C
84112Aminsure
84450Transferase Aspartate Amino Ast Sgot
84460Transferase Alanine Amino Alt Sgpt
84703Chorionic Gonadotropin Assay
85007Blood Count Smear Mcrscp w/Mnl Difrntl WBC Count
85013Spun Hematocrit
85014Blood Count Hematocrit
85018Blood Count Hemoglobin
85025Blood Count Complete Auto & Auto Difrntl WBC Count
85027Blood Count Complete Automated
85048WBC
85610Prothrombin Time
85651Sedimentation Rate
86308Heterophile Antibodies Screen
86403Particle Agglutination (Rapid Strep)
86580TB (INTRADERMAL & TINE)
87081Cul Prsmptv Pthgnc Organism Scrn w/Colony Estimj
87210Smr Prim Src Wet Mount Nfct Agt
87220KOH—tissue exam for fungi
87420Iaad Eia Respiratory Synctial Virus-Infectious agent antigen detection by immunoassay technique
87430Strep Screen
87800Infectious agent detection by nucleic acid -ladna Multiple Organisms Direct Probe TQ
  For laadiado, infectious agent antigen detection by immunossay with direct optical observation for these:
87801Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) technique
87804Iaadiadoo Influenza
87807Iaadiadoo Respiratory Synctial Virus- Infectious agent antigen detection by immunoassay with direct optical observation; respiratory syncytial virus
87880Iaadiadoo Streptococcus Group A
88720Bilirubin Total Transcutaneous
89060Crystal Id Light Microscopy Alys Tiss/Any Fluid
80305Drug test(s), presumptive, any number of drug classes, any number of devices or procedures
80306Drug test(s), presumptive, any number of drug classes, any number of devices or procedures
87502Infectious agent detection by nucleic acid (DNA or RNA); influenza virus
87651Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique
83036Hemoglobin; glycosylated (A1C)
83037Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use
87634Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe technique

COVID-19 Testing: Special guidance is in place during the disaster declaration period regarding COVID-19 testing; please refer to the Provider Alert that posted titled COVID-19 Testing expanded to include Out-of-Network (OON) Laboratories. 

Here is a link to the alert: http://www.thecheckup.org/2021/01/08/provider-alert-covid-19-disaster-declaration-covid-19-testing-expanded-to-include-out-of-network-oon-laboratories-2/ 

If you have any questions, please email Provider Network Management at: providerrelations@texaschildrens.org. 

For access to all provider alerts,log into: www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.